MétaCan
Menu
← Back to cohort
Record W7117449343 · doi:10.1158/2326-6066.cir-25-0583

The CCL17–CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

2025· article· en· W7117449343 on OpenAlexafffund
Madelyn Jean Abraham, Cynthia Guilbert, Natascha Gagnon, Christophe Gonçalves, Alexandre Benoit, Kelly Tran, Owen Hiltebrand, Ryan N. Rys, Samuel E.J. Preston, Ryan D. Morin, Wilson H. Miller, Nathalie A. Johnson, Sonia V. del Rincón, Koren K. Mann

Bibliographic record

VenueCancer Immunology Research · 2025
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsSimon Fraser UniversityMcGill UniversityJewish General Hospital
FundersCole FoundationCanadian Cancer SocietyLeukemia and Lymphoma Society of CanadaCancer Research Society
KeywordsLymphomaInfiltration (HVAC)ChemokineSTAT proteinEx vivoIn vivoChemokine receptorMutantDoxorubicinSTAT3

Abstract

fetched live from OpenAlex

Relapsed and refractory diffuse large B-cell lymphoma (rrDLBCL) presents a significant challenge in hematology-oncology, with approximately 30% to 40% of patients with DLBCL experiencing relapse or resistance to treatment. This underscores the urgent need to better understand the molecular mechanisms governing therapeutic resistance. Signal transducer and activator of transcription 6 (STAT6) has been previously identified as a gene with recurrent D419 gain-of-function mutations in rrDLBCL. We demonstrated previously that when STAT6D419 mutations are present in DLBCL tumor cells, transcription of the chemokine CCL17 (aka TARC) is increased, and tumors have increased infiltration of CD4+ T cells. However, the implication of increased T-cell infiltration has not been reported previously. In the present study, we developed a mouse model of STAT6D419N mutant DLBCL that recapitulates the critical features of human STAT6D419-mutant DLBCL, including increased expression of phospho-STAT6, increased CD4+ T-cell invasion, and resistance to doxorubicin treatment. We report CD4+ T cells in STAT6D419N tumors exhibit higher expression of the receptor for CCL17, CCR4. Using ex vivo functional assays, we demonstrated that STAT6D419N tumor cells are directly chemoattractive to CCR4+ CD4+ T cells, and CCR4 inhibition using a small-molecule antagonist reduced CD4+ T-cell infiltration into STAT6D419N tumors and made STAT6D419N tumors regain therapeutic sensitivity to doxorubicin. Using PhenoCycler imaging of human rrDLBCL samples, we found that STAT6D419 tumors have increased expression of phospho-STAT6 and increased cellular interactions between phospho-STAT6+ tumor cells and CD4+/CCR4+ CD4+ T cells. Thus, our data identify CCR4 as a therapeutic target in STAT6D419-mutant rrDLBCL.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.364
Teacher spread0.331 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueCancer Immunology Research→Same topicLymphoma Diagnosis and Treatment→French-language works237,207→